Legal Alerts
-
FDA’s Coronavirus Treatment Acceleration Program (CTAP): Hope for a COVID-19 Cure
-
The EEOC Provides Further Guidance During COVID-19
-
Businesses, Fraud, and the CARES Act: Insights on Government Enforcement Defense and Prevention
-
SEC Guidance: Public Statements of Municipal Issuers Subject to Antifraud Provisions
-
$30 Billion Under CARES Act Comes With Strings Attached – What Do You Need To Know?
-
Physicians Face Regulatory Exposure for Prescribing COVID-19 Drugs Cited by President Trump
-
Boards of Education Need to Consider Soon How They’ll Address Charter School Applications
-
New DOJ Guidance Addresses Drug prescriptions, Price-Gouging, and Antitrust Concerns in the Wake of COVID-19
-
Coronavirus-Related Business Interruption Insurance Claims In Pennsylvania
-
Tax-Exempt Debt Payment Deferrals For Municipal Securities